QUOIN PHARMACEUTICALS LT-ADR (QNRX) Institutional Ownership Changes & 13F Activity
QUOIN PHARMACEUTICALS LT-ADR (QNRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ikarian Capital, Llc, Woodline Partners Lp, Stonepine Capital Management, Llc, Aberdeen Group Plc, and Millennium Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, Llc | Buy | +211,538 | — | 211,538 | $3.05M | Q4 2025 | Feb 18, 2026 |
| Woodline Partners Lp | Buy | +79,582 | — | 79,582 | $1.15M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +74,817 | — | 74,817 | $1.08M | Q4 2025 | Feb 17, 2026 |
| Summittx Capital, L.P. | Buy | +64,795 | — | 64,795 | $934.99K | Q4 2025 | Feb 17, 2026 |
| Boothbay Fund Management, Llc | Buy | +59,838 | — | 59,838 | $863.46K | Q4 2025 | Feb 17, 2026 |
| Adar1 Capital Management, Llc | Buy | +58,230 | — | 58,230 | $840.26K | Q4 2025 | Feb 17, 2026 |
| Resolute Capital Asset Partners Llc | Buy | +30,000 | — | 30,000 | $432.90K | Q4 2025 | Feb 17, 2026 |
| Stonepine Capital Management, Llc | Buy | +78,189 | — | 78,189 | $1.13M | Q4 2025 | Feb 13, 2026 |
| Centiva Capital, Lp | Buy | +12,053 | — | 12,053 | $173.93K | Q4 2025 | Feb 13, 2026 |
| Morgan Stanley | Buy | +3,000 | — | 3,000 | $43.29K | Q4 2025 | Feb 13, 2026 |
| Rhumbline Advisers | Buy | +1,666 | — | 1,666 | $24.03K | Q4 2025 | Feb 13, 2026 |
| Soleus Capital Management, L.P. | Buy | +25,000 | — | 25,000 | $360.75K | Q4 2025 | Feb 12, 2026 |
| Simplify Asset Management Inc. | Buy | +17,448 | — | 17,448 | $251.78K | Q4 2025 | Feb 09, 2026 |
| Sbi Securities Co., Ltd. | Buy | +247 | — | 247 | $3.56K | Q4 2025 | Feb 03, 2026 |
| Aigh Capital Management Llc | Buy | +49,323 | — | 49,323 | $711.73K | Q4 2025 | Feb 02, 2026 |
| Ubs Group Ag | Buy | +17 | — | 17 | $245.00 | Q4 2025 | Jan 29, 2026 |
| Aberdeen Group Plc | Buy | +75,000 | — | 75,000 | $1.08M | Q4 2025 | Jan 16, 2026 |
| Gamma Investing Llc | Buy | +2,084 | — | 2,084 | $30.07K | Q4 2025 | Jan 05, 2026 |
Frequently asked questions about QNRX activity
Which institutional owners are buying QNRX?
Institutional owners buying QNRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in QNRX activity?
"Buy" means an investor increased their reported position in QNRX compared to the prior reporting period. This reflects growing exposure to QUOIN PHARMACEUTICALS LT-ADR (QNRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in QNRX increasing?
Institutional interest in QNRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related QNRX Institutional Insights
- QNRX Overview
- QNRX 13F Institutional Holders
- QNRX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- QNRX Insider Trading & SEC Form 4 Activity
- QNRX Articles
- Top Institutional Investor Stock Rankings